跳至主要内容
临床试验/TCTR20171106003
TCTR20171106003招募中4 期

High flow nasal oxygen for prevention of intubation in acute non-hypercapnic hypoxemic respiratory failure in immunocompromised patients, a randomized trial

Faculty of medicine, Chiang Mai University0 个研究点目标入组 74 人开始时间: 2017年11月6日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
74

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • all the following
  • 1.Immunocompromised patients: solid or hematologic malignancy, received immunosuppressive drug or steroid at a dose> 20 mg/day of prednisolone for > 30 days, HIV infection
  • 2.Require nasal low-flow oxygen of 4 L/min to maintain PaO2 above 60 mmHg or SpO2> 90% for > 1 hour
  • 3.Age >= 18 years

排除标准

  • 1.PaCO2> 45 mmHg
  • 2.Post-extubation respiratory failure (respiratory failure within 48 hr after extubation)
  • 3.Life-threatening ARF requiring immediate IMV
  • 5.Active pulmonary tuberculosis
  • 6.Contraindications to NIV
  • 7.A do-not-intubate order
  • 8.Patients refused to participate the study

研究者

发起方
Faculty of medicine, Chiang Mai University

相似试验

High flow nasal oxygen for prevention of intubation... | 临床试验